Health Care: Drugs

Illumina Inc (ILMN: NASDAQ)

$216.7 -2.6 | -1.19%
08/03/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 219.30
52 Week High 242.37
52 Week Low 145.12
Avg. Daily Vol. (Mil) 1.38
Beta (3 year) 0.40
Share Related Items
Mkt Cap (Mil) 31,601.13
Shares Out (Mil) 144.10
Float (Mil) 142.48
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.40
Current Ratio 2.90
LT Debt/ Equity 0.61
Total Debt / Equity 0.80
Valuation Ratios
Price Earnings 67.10
Price/Sales 15.26
Price/Book 19.47
Price/Cash Flow 54.20
Per Share Data
Earnings 3.27
Sales 14.37
Book Value 11.27
Cash Flow 4.05
Business Summary
Illumina Inc providessequencing-and array-based solutions for genetic analysis. Itsproducts enabled researchers to explore DNA, helping them create the first map of gene variations associated with health, disease, and drug response.
General Information
5200 Illumina Way
San Diego, CA 92122
www.illumina.com
Industry : Drugs
Sector: Health Care
Employees: 3700
CEO: Jay T. Flatley
Short Interest
Current Month (Mil) 4.01
Previous Month (Mil) 4.14
Short Interest Ratio (Days) 3.10
Management Effectiveness
Return on Equity 26.50
Return on Assets 12.30
Return on Investments 16.40
Profitability
Gross Margin 78.20
EBIT Margin 29.60
Profit Margin 23.50

Portfolios with ILMN

Latest ILMN Headlines from TheStreet

More Financial News for ILMN

Press Releases for ILMN

See All Press Releases

Partner Headlines for ILMN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter